Keystone Heart
Herzliya, Tel Aviv, Israel
About Keystone Heart
Keystone Heart aspires to be the world leader in embolic cerebral protection for cardiovascular procedures. To develop and manufacture cerebral protection devices, focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, AF ablation and other structural heart procedures. Cerebral function is the essence of quality of life. Preserving brain reserve throughout medical procedures is a key component to procedural success and patient care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.0M
- Funding stage: M&A
- Last round: Series B (May 2014)
- Website: keystoneheart.com
- Phone: 972 9 950 8089
Industries & Categories
Health Care, Health Diagnostics, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/keystone-heart-2577879 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.